Skip to main content
Glama

AlpineDataWorks Intelligence Server

Drug Recall Activity Index

adw.adw_552
Read-only

Returns a 0-100 US drug recall enforcement intensity score (severity-weighted openFDA recalls: Class I=3, II=2, III=1, trailing 90d vs prior 90d) with trend, by_class counts, top_reason driver, and the 10 latest Class I/II recalls (firm, product, reason, date). Call when the user asks about FDA drug recalls, pharma safety enforcement, or manufacturing failure modes, or when timing supplier audits, formulary reviews, or pharma supply-chain risk decisions. Updates: daily.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
daysNoOptional: return a daily HISTORY series of the last N days (up to 5 years of real archived data) instead of the current snapshot. History requires Gold tier; without it, the current snapshot is returned.

TDQS

A4.1/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, and the description adds meaningful behavioral context: the exact severity-weighting formula, the trailing 90-day comparison window, the list of returned data elements (trend, by_class, top_reason, 10 latest recalls), and the daily update cadence. This goes beyond the annotations without contradicting them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single dense sentence covering the returned data, followed by a clear usage trigger sentence and a brief update frequency note. It is efficient and front-loaded, though the first sentence is long and packed; no filler words. Every clause earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining what the tool returns. It does so thoroughly, listing the score, trend, by_class counts, top_reason driver, and the 10 latest recalls. It also notes the update frequency. A minor gap is the lack of explicit return format structure, but the listed components are sufficient for agent planning.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema description covers the single optional 'days' parameter fully (100% coverage), including its purpose, range, and Gold tier requirement. The description does not add additional parameter semantics, but with full schema coverage, a baseline of 3 is appropriate. The description does imply a snapshot vs history distinction, but that is already in the schema description.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly defines a specific verb ('Returns') and a well-specified resource: a 0-100 US drug recall enforcement intensity score with detailed weighting rules (Class I=3, II=2, III=1, trailing 90d vs prior 90d). It enumerates included components (trend, by_class counts, top_reason driver, latest recalls), which distinguishes it from the large sibling tool list.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states when to call it: 'Call when the user asks about FDA drug recalls, pharma safety enforcement, or manufacturing failure modes, or when timing supplier audits, formulary reviews, or pharma supply-chain risk decisions.' This gives clear context, though it does not mention when not to use it or name specific alternative tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation1/5

With 318 tools named adw.adw_###, agents cannot tell them apart without reading full descriptions. Multiple tools cover the same domain (e.g., at least three USD strength scores: adw_055, adw_250, adw_580; four supply-chain stress scores: adw_009, adw_019, adw_020, adw_547), making misselection highly likely.

Naming Consistency3/5

The vast majority follow a consistent numeric ID pattern (adw.adw_###), but a small set breaks this with descriptive snake_case names (adw.catalog, adw.sample, adw.county_cancer, etc.). The numeric IDs are predictable but convey no semantic meaning, mixing with the few named tools and creating moderate inconsistency.

Tool Count1/5

318 tools is far beyond any reasonable scope for an intelligence server; even the largest sophisticated APIs rarely exceed 50. This extreme count suggests poor curation and will overwhelm agents with choice, making efficient tool selection impractical.

Completeness3/5

The server covers an extremely broad range of domains (crypto, macro, supply chain, healthcare, climate, county demographics), and includes discovery tools like adw.catalog and adw.sample. However, the surface is redundant and not systematically complete—many overlapping indices exist while other potentially valuable operations (e.g., raw data export, historical trend queries) are missing, leaving moderate gaps.

Resources